Date: June 16, 2022
Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST)
Although significant advancements have been made in CMV diagnostic testing, universal screening during pregnancy has still not been substantially implemented or recommended. The burden of the disease related to congenital CMV is significant, as it is the leading non-genetic cause of hearing loss and neurodevelopmental disabilities in children. Despite its clinical significance, congenital CMV often goes undetected because many infected infants are asymptomatic at birth.1 While early diagnosis and intervention are fundamental, prevention of maternal infection, education and optimization of antiviral therapy can help to reduce the burden. This presentation highlights the clinical importance of congenital CMV infection, diagnosis, management, the developments in laboratory diagnostics, and how we can move forward to further reduce the impact of congenital CMV globally.
1. Marsico, Concetta, and David W Kimberlin. “Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment.” Italian journal of pediatrics vol. 43,1 38. 17 Apr. 2017, doi:10.1186/s13052-017-0358-8.
- Describe the clinical spectrum and outcomes of congenital CMV infections
- Realize the importance screening/diagnosis and understand the role of diagnostics
- Recognize the opportunities for prevention, management, and therapeutic strategies
Webinars will be available for unlimited on-demand viewing after live event.